Global Heart Lung Machine Market is valued at 290 million US$ in 2018 and will reach 490 million US$ by the end of 2025, growing at a CAGR of 6.9% | Valuates Reports
Heart Lung Machine is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The objectives of this study are to define, segment, and project the size of the Heart Lung Machine market based on company, product type, end user and key regions.
Read More: https://reports.valuates.com/sreport/QYRE-Auto-14B311/Global_Heart_Lung_Machine_Market
This report studies the global market size of Heart Lung Machine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heart Lung Machine in these regions.
This research report categorizes the global Heart Lung Machine market by top players/brands, region, type and end user. This report also studies the global Heart Lung Machine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 53% of Heart Lung Machine and made more than 56% of revenue share in 2015. MAQUET followed as second produced about 13% in 2015.
Through the above research we tend to believe that Sorin is the most important player in the market and it will occupy a major share of the market in the future. The competition will become more intense, companies will play more and more attention to developing regions in the future.
The study objectives of this report are:
To study and analyze the global Heart Lung Machine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Heart Lung Machine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Heart Lung Machine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Heart Lung Machine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Get Sample Copy Of This Report https://reports.valuates.com/request/sample/QYRE-Auto-14B311/Global_Heart_Lung_Machine_Market
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by Product
Single Roller Pump Heart Lung Machine
Double Roller Pump Heart Lung Machine
Market size by End User
Lung Transplant Operation
Acute Respiratory Failure Treatment
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heart Lung Machine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
Avail Discount On This Report https://reports.valuates.com/request/discount/QYRE-Auto-14B311/Global_Heart_Lung_Machine_Market
About Valuates Reports :
Our aim is to collate unparalleled Market insights and notify our customers as and when it happens.
Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of silicon valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.
For U.S. Toll Free Call +1 (425) 388-2538
For IST Call +91-8040957137
To know more visit us on:
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Heart Lung Machine Market is valued at 290 million US$ in 2018 and will reach 490 million US$ by the end of 2025, growing at a CAGR of 6.9% | Valuates Reports here
News-ID: 1763484 • Views: 297
More Releases from Valuates Reports
Global Electric Vehicle (EV) Battery Market Size was Valued At $23 Billion in 20 …
Electric Vehicle Battery Market Statistics - 2025 A battery is used as a secondary power source in automobiles. An electric vehicle (EV) battery is a secondary (rechargeable) battery. It uses chemical energy stored in rechargeable battery packs for power and therefore does not require any combustion engine for propulsion. An electric vehicle battery or traction battery powers the propulsion of battery electric vehicles. In recent years, consumers are more inclined toward battery
3D Cell Culture Market Research Report : Market size, Market Forecast, Market Sh …
The global 3D Cell Culture market is valued at 510 million US$ in 2018 and will reach 1210 million US$ by the end of 2025, growing at a CAGR of 13.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the 3D Cell Culture market based on company, product type, end user and key regions. A 3D cell culture is an artificially-created environment in
Connected Car Market Report | Market size, Market Forecast, Market Share, Indust …
The Global Connected Car Market was valued at $63,026.0 million in 2017, and is projected to reach $225,158.0 million by 2025, registering a CAGR of 17.1% from 2018 to 2025. In 2017, North America garnered the highest share in the global connected car market. Connected car facilitates connectivity on wheels offering comfort, convenience, performance, safety, and security along with powerful network technology. This enables the driver to connect with online platforms,
Global Aircraft Engine market size will reach 57.28 Billion US$ by 2025, growing …
GLOBAL AIRCRAFT ENGINE MARKET TRENDS: The turbofan segment currently holds a significant share in the demand for aircraft engines and may continue to do so over the forecast period. Turbofan engines are most commonly used in the military and commercial sectors. New aircraft programs such as COMAC C919 and Boeing 777X, which are still in service, are powered by turbofan engines of the latest generation. “The global Aircraft Engine market will reach
More Releases for Lung
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ https://www.pharmaproff.com/request-sample/1126 The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis Some of the types of the condition include
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Lung Cancer Surgery Market Forecasts (2016-2021)
Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach USD 30.32 billion by 2021 with a CAGR of 6.92 %. Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are many ways to treat Lung Cancer. Some of them are Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves removal of infected section from lungs. There are many
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
Europe Lung Cancer Drug Pipeline Analysis
The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts